At a glance
- Originator Chiron Corporation
- Class Antineoplastics; Antirheumatics
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Rheumatoid arthritis
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 06 Jun 2001 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)
- 16 Nov 1998 New profile